References
1. Wang H, Li T, Barbarino P, Gauthier S, Brodaty H, Molinuevo JL, Xie
H, Sun Y, Yu E, Tang Y, Weidner W. Dementia care during COVID-19.
Lancet. 2020;395(10231):1190.
2. Caraci F, Sultana J, Drago F, Spina E. Clinically relevant drug
interactions with anti-Alzheimer’s drugs. CNS & Neurological
Disorders-Drug Targets. 2017;16(4):501-13.
3. University of Liverpool. COVID-19 Drug Interactions. 2020.
https://www.covid19-druginteractions.org. Accessed 21 April, 2020.
4. Pytliak M, Vargová V, Mechírová V. Drugs and hypoglycemia.
Hypoglycemia–causes and occurrences. Shanghai: InTechOpen.
2011:131-48.
5. Pasqualetti G, Tognini S, Calsolaro V, Polini A, Monzani F. Potential
drug–drug interactions in Alzheimer patients with behavioral symptoms.
Clinical Interventions in Aging. 2015;10:1457.